Miles D, Gligorov J, Andre F, Cameron D, et al. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer. Ann Oncol 2021 Jul 1. pii: S0923-7534(21)02026.
PMID: 34219000